has resolved as follows: 1. Approved to propose to the Extraordinary General Meeting of Shareholders No.1/2018 to consider and approve the increase in the Company’s registered capital Approved to
Newly-Issued Shares by Listed Companies in a Private Placement, The market price used in determining the offering price is the fair value appraised by the financial advisor in the account approved by the
No. 1/2019 held on 18 February 2019 and approved by the Company’s Board of Directors at the meeting No. 2/2019 held on 18 February 2019, respectively. Also, on this occasion, the Company would like to
Managing Director Director 3. Mr. Nozomu Otsuka Deputy Managing Director Director (11) Opinion by The Board of Directors : The Board of Directors approved the transaction to purchase above assets from Wien
auditor, considered by the Audit Committee, and approved by the Company’s Board of Directors on February 22, 2 0 1 9 , the Company wishes to report further clarifications in summary as follows: Summary of
The Board of Directors Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.1/2020, held on February 25, 2020, has approved the financial statements of the Company and its
. This transaction must be approved by the Board of Directors and disclosed to the Stock Exchange of Thailand but need not approval by the General Shareholders Meeting. Data from the financial statements
auditor and the Audit Committee at the meeting No. 5/2017 held on 8 August 2017 and approved by the Company’s Board of Directors at the meeting No. 5/2017 held on 9 August 2017, respectively. Also, on this
approved by the Board of Directors at the Meeting No. 4/2017 convened on August 10, 2017, respectively. Also, on this occasion, the Company would like to report its operating results as detailed below. 1